乳腺癌免疫治疗中的公共新抗原 (综述)
Natthaporn Sueangoen1, Peti Thuwajit2, Pa-Thai Yenchitsomanus3
1Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
International journal of molecular medicine
|June 21, 2024
概括
公开的新抗原来源于乳腺癌的共同基因突变,为开发"现成"免疫疗法提供了一个有前途的途径. 本综述探讨了它们在乳腺癌治疗中的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 基因组学就是基因组学.
背景情况:
- 乳腺癌是全球最常见的癌症,也是癌症死亡的主要原因.
- 虽然遗传学起着作用,但大多数乳腺癌是由零星突变引起的,而不是遗传的 (<15%有家族病史).
- 来自体质突变的新抗原是现代癌症基因组学和免疫治疗的关键目标.
研究的目的:
- 审查共享或公共新抗原在乳腺癌中的治疗潜力.
- 突出乳腺癌中常见的热点突变,这些突变产生公共的新抗原.
- 讨论针对乳腺癌的公开的基于新抗原的治疗方法的临床应用.
主要方法:
- 文献综述侧重于癌症基因组学和免疫治疗.
- 分析乳腺癌中常见的遗传突变.
- 检查现有和潜在的基于新抗原的治疗策略.
主要成果:
- 公开的新抗原为开发广泛适用的癌症治疗提供了重大机会.
- 识别乳腺癌中的特定热点突变可以指导公共新抗原的选择.
- 基于新抗原的疗法,特别是针对公共新抗原的疗法,显示出对"现成"癌症治疗的希望.
结论:
- 公开的新抗原是乳腺癌的可行的治疗点.
- 针对共享突变可以导致更容易获得和可扩展的癌症免疫疗法.
- 对公开的基于新抗原的治疗方法的进一步研究可能会彻底改变乳腺癌治疗.
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cancer Vaccines
352
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
352
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


